Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis
- PMID: 24584616
- PMCID: PMC4520725
- DOI: 10.3747/pdi.2013.00232
Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis
Abstract
♦
Background: Peritoneal dialysis (PD) solutions containing icodextrin as the osmotic agent have advantages during long dwells. The glucose polymers that constitute icodextrin are a heterogeneous mix of molecules with a polydispersity [ratio of weight-average to number-average molecular weight (Mw/Mn)] of approximately 2.6. The present study evaluates whether modifications in the polydispersity and concentration of glucose polymers can improve ultrafiltration (UF) without an associated increase in carbohydrate absorption (CA). ♦
Methods: Computer simulations using a three-pore model of peritoneal transport during a long dwell in PD patients predict that, in general, compared with 7.5% icodextrin, glucose polymers with a Mw greater than or equal to 7.5 kDa, a polydispersity less than 2.6, and concentrations greater than 7% could achieve higher UF without higher CA. Based on the simulations, we hypothesized that, compared with 7.5% icodextrin, glucose polymers with a Mw of 18 - 19 kDa and a polydispersity of 2.0 at 11% concentration could achieve higher UF without a higher CA. We tested this hypothesis in experimental studies using 8-hour dwells in New Zealand White rabbits. In those studies, UF was measured by complete fluid collection, and CA was measured by subtracting the total carbohydrate in the collected fluid from the carbohydrate initially infused. ♦
Results: The UF was higher with 11% 19 kDa glucose polymer than with 7.5% icodextrin (mean ± standard deviation: 89 ± 31 mL vs 49 ± 15 mL; p = 0.004) without higher CA (5.2 ± 0.9 g vs 5.0 ± 0.9 g, p = 0.7). Similar results were seen with the 11% 18 kDa glucose polymer, which, compared with 7.5% icodextrin, resulted in higher UF (mean ± standard deviation: 96 ± 18 mL vs 66 ± 17 mL; p < 0.001) without higher CA (4.8 ± 0.7 g vs 5.2 ± 0.6 g, p = 0.2). ♦
Conclusions: The findings demonstrate that, compared with 7.5% icodextrin solution, long-dwell PD solutions containing 11% glucose polymers with a Mw of 18-19 kDa and a polydispersity of 2.0 can provide higher UF without higher CA.
Keywords: Carbohydrate absorption; glucose polymer; molecular weight; polydispersity; rabbits; ultrafiltration.
Copyright © 2015 International Society for Peritoneal Dialysis.
Figures





Similar articles
-
Ultrafiltration characteristics of glucose polymers with low polydispersity.Perit Dial Int. 2013 Mar-Apr;33(2):124-31. doi: 10.3747/pdi.2012.00009. Epub 2012 Nov 1. Perit Dial Int. 2013. PMID: 23123667 Free PMC article.
-
Icodextrin Simplifies PD Therapy by Equalizing UF and Sodium Removal Among Patient Transport Types During Long Dwells: A Modeling Study.Perit Dial Int. 2016 Jan-Feb;36(1):79-84. doi: 10.3747/pdi.2013.00081. Epub 2014 Sep 2. Perit Dial Int. 2016. PMID: 25185017 Free PMC article.
-
Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.Perit Dial Int. 2013 Nov-Dec;33(6):646-54. doi: 10.3747/pdi.2012.00261. Perit Dial Int. 2013. PMID: 24335125 Free PMC article.
-
Icodextrin: a review of its use in peritoneal dialysis.Drugs. 2003;63(19):2079-105. doi: 10.2165/00003495-200363190-00011. Drugs. 2003. PMID: 12962523 Review.
-
Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.Am J Kidney Dis. 2020 Jun;75(6):830-846. doi: 10.1053/j.ajkd.2019.10.004. Epub 2020 Feb 4. Am J Kidney Dis. 2020. PMID: 32033860
Cited by
-
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis.J Nephrol. 2021 Apr;34(2):503-519. doi: 10.1007/s40620-020-00804-2. Epub 2020 Aug 7. J Nephrol. 2021. PMID: 32767274 Free PMC article. Review.
-
Water removal during automated peritoneal dialysis assessed by remote patient monitoring and modelling of peritoneal tissue hydration.Sci Rep. 2021 Aug 2;11(1):15589. doi: 10.1038/s41598-021-95001-x. Sci Rep. 2021. PMID: 34341373 Free PMC article.
-
Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis.Sci Rep. 2023 Apr 21;13(1):6526. doi: 10.1038/s41598-023-33480-w. Sci Rep. 2023. PMID: 37085652 Free PMC article.
References
-
- Blake PG. Icodextrin: fifteen years and counting. Perit Dial Int 2009; 29:367–9. - PubMed
-
- Vonesh EF, Story KO, Douma CE, Krediet RT. Modeling of icodextrin in PD Adequest 2.0. Perit Dial Int 2006; 26:475–81. - PubMed
-
- Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546–54. - PubMed
-
- Holmes CJ, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl 2006; 70:S104–9. - PubMed
-
- Cho Y, Johnson DW, Badve S, Craig JC, Strippoli GF, Wiggins KJ. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized clinical trials. Nephrol Dial Transplant 2013; 28:1899–907. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources